Home Top Movers What Prompted TENX Stock To Surge 17% In Last Session?

What Prompted TENX Stock To Surge 17% In Last Session?

The stock of Tenax Therapeutics, Inc. (NASDAQ: TENX) closed the previous session at $2.08, meaning its value has risen 307.76% higher than its 52-week low. In intraday trading, Tenax stock hit a low of $2.03 and a high of $2.47.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

A recent trading session has witnessed an intraday change of just 16.85% while TENX stock has had a 52-week high of $3.68 and a low of $0.51. An increase in TENX stock accompanied the positive results of a phase 2 study on its candidate for the treatment of cardiovascular disease.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

The TENX study found what?

A specialty pharmaceutical company, Tenax Therapeutics, focuses on identifying and developing products with high unmet medical needs for cardiovascular diseases and pulmonary diseases. TENX facilitates access to world-class scientific advisory teams, which include globally recognized experts in pulmonary hypertension.

Read More

On Friday, Tenax announced that it had published positive results from its Phase 2 HELP study that examined levosimendan’s efficacy in patients with Cardiopulmonary Hypertension associated with Heart Failure.

  • TENX has published a new publication titled Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Placebo-Controlled HELP Trial.
  • This article was published in the Journal of the American College of Cardiology.
  • Through this 6-week study, TENX examined the haemodynamics of individuals who were invasively monitored by their cardiovascular system as well as secondary clinical outcomes such as a 6-minute walk test.
  • According to the TENX study published in the journal, 84% of the participants responded.
  • The primary endpoint of exercise-PCWP was not significantly reduced by levosimendan, compared with placebo, but PCWP was effectively reduced across all phases of exercise.
  • Compared to a control group, 6 MWD experienced a 29.5 meter improvement from the levosimendan treatment.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

TENX’s further plans:

Levosimendan is currently in Phase 2 clinical trials to treat PH-HFpEF and developed by Tenax (TENX), which also has the rights to develop and commercialize this drug. Based on the TENX study’s results, further study of levosimendan in PH-HFpEF patients is warranted since this is the first drug that could demonstrate improved cardiomyopathy and improved six-minute walking distance compared to placebo.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Amarin Corporation plc (NASDAQ: AMRN) stock plunged in the premarket trading session; here’s why

In the premarket trading session, Amarin Corporation plc (AMRN) stock had plunged by -4.56% to $4.4. AMRN stock closed previous session at $4.61 gaining...

Why Second Sight Medical Products, Inc. (EYES) stock is Popping High today?

Second Sight Medical Products, Inc. (EYES) stock announced two-year results of its Orion Study after which the EYES stock price happened to be green...

Luokung Technology Corp. (LKCO) Stock Undergoes Volatility as Appeal Over CCMC Designation is Underway

Luokung Technology Corp. (LKCO) stock prices were down by 6.40% as of the market closing on May 11th, 2021, bringing the price per share...

Vista Gold Corp. (VGZ) Stock Inches Higher After Promising Q1 2021 Financial Reports

Vista Gold Corp. (VGZ) stock prices were up by an incremental 1.82% as of the market closing on May 11th, 2021, bringing the price...

Array Technologies, Inc. (ARRY) Stock Prices Stay Stable Despite Troubling Q1 2021 Financial Reports

Array Technologies, Inc. (ARRY) stock prices were up by a marginal 0.28% as of the market closing on May 11th, 2021, bringing the price...

Lucira Health Inc. (NASDAQ:LHDX) stock rallied today in the current trading session; here’s why

In the current trading session at last check, Lucira Health Inc. (LHDX) shares had surged by 15.32% to the price of $5.87. LHDX's stock...

PaySign, Inc. (PAYS) Stock Down Following Disclosure of Troubling Q1 2021 Financial Reports

PaySign, Inc. (PAYS) stock prices were down 15.0568% early in the trading day on May 12th, 2021, bringing the price per share down to...

Comstock Mining Inc. (NASDAQ:LODE) stock plunged in the current trading session; here’s why

In the current trading session at the last check, Comstock Mining Inc. (LODE) stock had plunged -3.25% to trade at $3.21. LODE stock previously...

Related News

Why Summit Wireless Technologies, Inc. (WISA) stock is Going high today?

Summit Wireless Technologies, Inc. (WISA) stock, a wireless sound technology company, provided an update for its first quarter ended March 31, 2021, today on...

Contextlogic Inc. (NASDAQ: WISH) stock rises during pre-market session. Let’s figure out why?

Contextlogic Inc. (NASDAQ: WISH) stock plunged by 0.84% at last close whereas the WISH stock price gains by 4.84% during pre-market session. WISH, which...

Biomerica Inc. (NASDAQ: BMRA) stock gains during pre-market. What’s driving it high?

Biomerica Inc. (NASDAQ: BMRA) stock declined by 17.23% at last close but later in pre-market session the BMRA stock soars by 13.78%. Biomerica is...

AgeX Therapeutics Inc. (NYSE:AGE) stock surged in the premarket trading session; here’s why

In the premarket trading session, at last check AGE stock surged by 7.2% to $1.34. AGE stock closed previous session at $1.25 losing -3.85%....

CuriosityStream Inc. (NASDAQ: CURI) stock fell during after-hour. Why is it so?

CuriosityStream Inc. (NASDAQ: CURI) stock declined by 3.37% at last close while the CURI stock continues to fall by 11.99% in the after-hour trading....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.